Bone Marrow TransplantationBone MarrowBone Marrow CellsTransplantation, HomologousGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesHematopoietic Stem Cell TransplantationAnemia, AplasticTransplantation ConditioningHematopoietic Stem CellsLeukemiaTransplantation ChimeraBone Marrow PurgingLiver TransplantationGraft SurvivalTissue DonorsBone Marrow DiseasesBusulfanHistocompatibility TestingStem CellsHistocompatibilityHematopoiesisBone Marrow ExaminationCyclophosphamideTransplantation, IsogeneicMice, Inbred C57BLBone Marrow NeoplasmsStem Cell TransplantationRadiation ChimeraKidney TransplantationRecurrenceCombined Modality TherapyLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTime FactorsRemission InductionHematologic NeoplasmsTreatment OutcomeImmunosuppressive AgentsPrecursor Cell Lymphoblastic Leukemia-LymphomaColony-Forming Units AssayGraft RejectionHepatic Veno-Occlusive DiseaseLeukemia, MyeloidBone RemodelingGraft vs Host ReactionTransplantation ImmunologyLymphocyte DepletionImmunosuppressionLymphoma, Non-HodgkinAcute DiseaseLeukocyte TransfusionChimeraMyelodysplastic SyndromesT-LymphocytesHeart TransplantationSevere Combined ImmunodeficiencyCell DifferentiationSurvival AnalysisHLA AntigensRetrospective StudiesHematologic DiseasesActuarial AnalysisCyclosporineLymphocyte TransfusionLung TransplantationPancytopeniaCells, CulturedBone DensityAntineoplastic Combined Chemotherapy ProtocolsFlow CytometrySpleenLeukocyte CountGranulocyte Colony-Stimulating FactorNuclear FamilyCarmustineAntigens, CD34Mice, Inbred BALB CCytarabineGraft vs Tumor EffectFollow-Up StudiesMultiple MyelomaSurvival RateOrgan TransplantationGraft vs Leukemia EffectCytomegalovirus InfectionsMelphalanBone ResorptionGranulocytesDisease-Free SurvivalLymphomaEtoposideMice, KnockoutCell SeparationImmunophenotypingStromal CellsFatal OutcomeCord Blood Stem Cell Transplantation